Headline
The latest stories from AHA Today.
The Small Business Administration released an interim final rule, effective immediately, on the process for Paycheck Protection Program borrowers to appeal certain SBA loan review decisions to the SBA Office of Hearings and Appeals.
The Department of Health and Human Services has extended to Sept. 13 the deadline for applying for its Public Health and Social Services Emergency Fund “Phase 2 General Distribution.” The previous deadline was Aug. 28.
The Centers for Medicare & Medicaid Services issued an interim final rule that, among other provisions, makes collecting and reporting COVID-19-data a condition of participation for hospitals that participate in Medicare.
Associations Now, the American Society of Association Executives’ magazine for nonprofit professionals, has named AHA to its list of “100 Associations That Will Save the World.”
The AHA urged the Centers for Medicare & Medicaid Services to reverse its calendar year 2021 Home Health Prospective Payment System Rate Update of 4.36% behavioral offset for the remainder of CY 2020 and beyond until all CY 2020 data are available for analysis.
The Democratic Republic of the Congo has reported 100 confirmed or probable Ebola cases and 43 deaths in Equateur Province since June 1, the World Health Organization reported.
Island child care programs reported just 52 confirmed or probable COVID-19 cases after reopening in June and July, according to a report released by the Centers for Disease Control and Prevention.
AHA Board Chair Melinda Estes, M.D., will be joined by Rachelle Schultz, president and CEO of Winona Health, for the next in a series of Leadership Rounds – short conversations on a range of key issues Dr. Estes will have with hospital and health system leaders from across the country.
An updated AHA resource examines the impact of the social determinants of health on patients and communities as they battle the COVID-19 public health emergency.
The Food and Drug Administration issued an emergency use authorization for investigational convalescent plasma to treat suspected or laboratory-confirmed COVID-19 in hospitalized patients.